The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Cross-regulation of TNF and IFN-α in autoimmune diseases
Open accessAbstract
Cytokines, most particularly TNF and type I IFN (IFN-αβ), have been long considered essential elements in the development of autoimmunity. Identification of TNF in the pathogenesis of rheumatoid arthritis and TNF antagonist therapy represent successes of immunology. IFN-αβ plays a major role in systemic lupus erythematosus (SLE), a prototype autoimmune disease characterized by a break of tolerance to nuclear components. Here, we show that TNF regulates IFN-α production in vitro at two levels. First, it inhibits the generation of plasmacytoid dendritic cells (pDCs), a major producer of IFN-αβ, from CD34 + hematopoietic progenitors. Second, it inhibits IFN-α release by immature pDCs exposed to influenza virus. Neutralization of endogenous TNF sustains IFN-α secretion by pDCs. These findings are clinically relevant, as five of five patients with systemic juvenile arthritis treated with TNF antagonists display overexpression of IFN-α-regulated genes in their blood leukocytes. These results, therefore, might provide a mechanistic explanation for the development of anti-dsDNA antibodies and lupus-like syndrome in patients undergoing anti-TNF therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
RetractedThe Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Self-citationCella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Caux, C., Dezutter-Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,554
Self-citationInduction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Self-citationAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Self-citationGómez‐Reino, J. J., Carmona, L., Valverde, V. R., Mola, E. M., & Montero, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11137 · Cited by 1,013
Immune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity
Kadowaki, N., Antonenko, S., Lau, J. Y.-N., & Liu, Y.-J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.219 · Cited by 849
Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., & McDevitt, H. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1233 · Cited by 627
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
From T to B and back again: positive feedback in systemic autoimmune disease
Shlomchik, M. J., Craft, J. E., & Mamula, M. J. (2001) · Nature Reviews Immunology · doi:10.1038/35100573 · Cited by 572
Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X.-L., Trinchieri, G., O'Garra, A., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020045 · Cited by 524
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon
Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., & Vilček, J. (1982) · Science · doi:10.1126/science.6176024 · Cited by 459
Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid Tumors
Rönnblom, L. E., Alm, G. V., & Öberg, K. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-178 · Cited by 455
IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS
Foulis, A., Farquharson, M., & Meager, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91128-7 · Cited by 446
Shedding of tumor necrosis factor receptors by activated human neutrophils.
Porteu, F., & Nathan, C. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.599 · Cited by 437
Aringer, M., Graninger, W. B., Steiner, G., & Smolen, J. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20576 · Cited by 342
Spits, H., Couwenberg, F., Bakker, A. Q., Weijer, K., & Uittenbogaart, C. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1775 · Cited by 322
Rönnblom, L., & Alm, G. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.f59 · Cited by 288
Induction of Type I Diabetes by Interferon-α in Transgenic Mice
Stewart, T. A., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J., & MacLachlan, N. J. (1993) · Science · doi:10.1126/science.8100367 · Cited by 285
VALLIN, H., BLOMBERG, S., ALM, G. V., CEDERBLAD, B., & RÖNNBLOM, L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00772.x · Cited by 252
Interferon-α and Autoimmune Thyroid Disease
Prummel, M. F., & Laurberg, P. (2003) · Thyroid · doi:10.1089/105072503322238809 · Cited by 221
Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., & Issazadeh-Navikas, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4776 · Cited by 200
Finkelman, F. D., Svetic, A., Gresser, I., Snapper, C., Holmes, J., Trotta, P. P., Katona, I. M., & Gause, W. C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1179 · Cited by 190
Kollias, G., & Kontoyiannis, D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00019-9 · Cited by 177
Caux, C., Saeland, S., Favre, C., Duvert, V, Mannoni, P., & Banchereau, J. (1990) · Blood · doi:10.1182/blood.v75.12.2292.2292 · Cited by 158
Self-citationEhlers, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii37 · Cited by 150
Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis
Yu, M., Nishiyama, A., Trapp, B. D., & Tuohy, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00160-3 · Cited by 147
Chen, W., Antonenko, S. V., Sederstrom, J. M., Liang, X., Chan, A. S. H., Kanzler, H., Blom, B., Blazar, B. R., & Liu, Y. (2003) · Blood · doi:10.1182/blood-2003-09-3058 · Cited by 144
Chabot, S., Williams, G., & Yong, V. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119571 · Cited by 142
Rönnelid, J., Tejde, A., Mathsson, L., Nilsson-Ekdahl, K., & Nilsson, B. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.1.37 · Cited by 130
Gottlieb, A. B. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01143-5 · Cited by 128
Båve, U., Vallin, H., Alm, G. V., & Rönnblom, L. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0519 · Cited by 104
Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers
Rothuizen, L. E., Buclin, T., Spertini, F., Trinchard, I., Munafo, A., Buchwalder, P.-A., Ythier, A., & Biollaz, J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00029-6 · Cited by 92
Etanercept-induced systemic lupus erythematosus
Swale, V. J., Perrett, C. M., Denton, C. P., Black, C. M., & Rustin, M. H. A. (2003) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2003.01411.x · Cited by 76
Regulation of CD40 ligand expression in systemic lupus erythematosus
Crow, M. K., & Kirou, K. A. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00004 · Cited by 68
Directing Autoimmunity to Nucleoprotein Particles
Hardin, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030130 · Cited by 39
Inhibition of Lupus by Genetic Alteration of the Interferon-α/β Receptor
Kono, D. H., Baccalà, R., & Theofilopoulos, A. N. (2003) · Autoimmunity · doi:10.1080/08916930310001624665 · Cited by 37
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
The multifaceted biology of plasmacytoid dendritic cells
Swiecki, M., & Colonna, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3865 · Cited by 1,131
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Self-citationVitiligo: Mechanisms of Pathogenesis and Treatment
Frisoli, M. L., Essien, K., & Harris, J. E. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100919-023531 · Cited by 618
Gottenberg, J.-E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510837103 · Cited by 611
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
BLANCO, P., PALUCKA, A., PASCUAL, V, & BANCHEREAU, J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.004 · Cited by 566
Self-citation
Metadata
- Authors
- Palucka, A. K., Blanck, J.-P., Bennett, L., Pascual, V., & Banchereau, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-02-22
- Volume
- 102
- Issue
- 9
- Pages
- 3372-3377
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2152507275
- Cited by
- 516
- References
- 45
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.